Dec 15 (Reuters) - Verastem Inc VSTM.O:
VERASTEM ONCOLOGY ANNOUNCES STRATEGIC TRANSITION PLAN TO ACCELERATE NEXT PHASE OF GROWTH
VERASTEM INC - JOHN JOHNSON APPOINTED AS CHAIRMAN OF THE BOARD
VERASTEM INC: RAMP 301 PHASE 3 CONFIRMATORY TRIAL TOPLINE DATA ANTICIPATED IN MID-2027
Source text: ID:nBw5KkrZha
Further company coverage: VSTM.O
((Reuters.Briefs@thomsonreuters.com;))